Spain · Delayed Price · Currency is EUR Atrys Health Statistics
Total Valuation
Atrys Health has a market cap or net worth of EUR 193.94 million. The enterprise value is 299.59 million.
| Market Cap | 193.94M |
| Enterprise Value | 299.59M |
Important Dates
The last earnings date was Thursday, September 10, 2026.
| Earnings Date | Sep 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Atrys Health has 75.91 million shares outstanding. The number of shares has decreased by -0.25% in one year.
| Current Share Class | 75.91M |
| Shares Outstanding | 75.91M |
| Shares Change (YoY) | -0.25% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 4.44% |
| Owned by Institutions (%) | 16.14% |
| Float | 42.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 23.91 |
| PS Ratio | 1.30 |
| PB Ratio | 1.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.02 |
| EV / EBITDA | 71.88 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.47, with a Debt / Equity ratio of 0.80.
| Current Ratio | 0.47 |
| Quick Ratio | 0.39 |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 28.59 |
| Debt / FCF | -13.61 |
| Interest Coverage | -0.53 |
Financial Efficiency
Return on equity (ROE) is -24.57% and return on invested capital (ROIC) is -3.05%.
| Return on Equity (ROE) | -24.57% |
| Return on Assets (ROA) | -1.08% |
| Return on Invested Capital (ROIC) | -3.05% |
| Return on Capital Employed (ROCE) | -3.94% |
| Weighted Average Cost of Capital (WACC) | 8.13% |
| Revenue Per Employee | 193,550 |
| Profits Per Employee | -127,645 |
| Employee Count | 763 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 64.70 |
Taxes
| Income Tax | -1.38M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.43% in the last 52 weeks. The beta is 0.52, so Atrys Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -7.43% |
| 50-Day Moving Average | 2.62 |
| 200-Day Moving Average | 2.76 |
| Relative Strength Index (RSI) | 40.54 |
| Average Volume (20 Days) | 64,538 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Atrys Health had revenue of EUR 147.68 million and -97.39 million in losses. Loss per share was -1.28.
| Revenue | 147.68M |
| Gross Profit | 24.58M |
| Operating Income | -7.71M |
| Pretax Income | -49.17M |
| Net Income | -97.39M |
| EBITDA | 249,000 |
| EBIT | -7.71M |
| Loss Per Share | -1.28 |
Balance Sheet
The company has 12.84 million in cash and 118.42 million in debt, with a net cash position of -105.59 million or -1.39 per share.
| Cash & Cash Equivalents | 12.84M |
| Total Debt | 118.42M |
| Net Cash | -105.59M |
| Net Cash Per Share | -1.39 |
| Equity (Book Value) | 147.49M |
| Book Value Per Share | 1.94 |
| Working Capital | -63.03M |
Cash Flow
In the last 12 months, operating cash flow was -4.73 million and capital expenditures -3.97 million, giving a free cash flow of -8.70 million.
| Operating Cash Flow | -4.73M |
| Capital Expenditures | -3.97M |
| Depreciation & Amortization | 7.96M |
| Net Borrowing | -126.40M |
| Free Cash Flow | -8.70M |
| FCF Per Share | -0.11 |
Margins
Gross margin is 16.65%, with operating and profit margins of -5.22% and -65.95%.
| Gross Margin | 16.65% |
| Operating Margin | -5.22% |
| Pretax Margin | -33.30% |
| Profit Margin | -65.95% |
| EBITDA Margin | 0.17% |
| EBIT Margin | -5.22% |
| FCF Margin | n/a |
Dividends & Yields
Atrys Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.25% |
| Shareholder Yield | 0.25% |
| Earnings Yield | -50.71% |
| FCF Yield | -4.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Atrys Health is 4.83, which is 89.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 4.83 |
| Price Target Difference | 89.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 8.66% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Atrys Health has an Altman Z-Score of 0.09 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.09 |
| Piotroski F-Score | 4 |